PIK3CA and lung carcinoma: Recent studies have shown in the lung cancers with mutant PIK3CA, there are also mutations at other driver oncogenes, such as EGFR, KRAS, BRAF, MEK, and anaplastic lymphoma kinase (ALK) [141].